Torii Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Torii Pharmaceutical Co. Ltd.
Brandes International Small Cap Equity Fund
448,100
1.56%
-30,300
0.71%
03/31/2018
Government Pension Fund - Global (The)
267,799
0.93%
116,299
0%
12/31/2017
DFA International Small Cap Value Portfolio
173,400
0.6%
25,800
0.02%
04/30/2018
Nomura Asset TOPIX ETF Fund (1306)
169,400
0.59%
-25,100
0.01%
07/31/2018
Vanguard Total International Stock Index Fund
162,358
0.56%
0
0%
07/31/2018
DFA Japanese Small Company Series
102,700
0.36%
0
0.06%
01/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
83,200
0.28%
-12,800
0.01%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
76,300
0.27%
0
0.01%
08/20/2018
DFA International Core Equity Portfolio
68,900
0.24%
1,300
0.01%
04/30/2018
Vanguard Developed Markets Index Fund
65,200
0.23%
0
0%
07/31/2018
| Address |
Torii Nihonbashi Building
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.torii.co.jp |
| Updated |
07/08/2019 |
| Torii Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products are mainly used in the areas of renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases and allergies, active bacteria formulation (laxative), tocolysis, eclampsia and others. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan. |
